GlassScriptPhysician profile
Kimberly Udell
NPI 1619059201
$3,004.78
in general payments reported to CMS, 2019-2025
26 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $232 · 2021: $532 · 2022: $554 · 2023: $653 · 2024: $266 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.17 |
| Education | $292.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $553.02 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $474.84 | 2023-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $326.54 | 2019-2023 | Wegovy |
| Mayne Pharma Commercial LLC | $323.43 | 2021-2025 | |
| Pfizer INC. | $202.46 | 2019-2024 | |
| Organon LLC | $137.59 | 2021-2025 | Nexplanon |
| Lilly USA, LLC | $107.41 | 2023-2025 | Zepbound, Jardiance, Mounjaro |
| Lupin INC. | $106.64 | 2019-2021 | |
| Roche Diagnostics Corporation | $99.14 | 2019-2021 | |
| Avion Pharmaceuticals | $96.84 | 2019-2020 | |
| Therapeuticsmd, INC. | $87.43 | 2019-2021 | |
| Agile Therapeutics, INC. | $66.04 | 2021-2023 | Twirla |
| Millicent US INC | $61.33 | 2024-2025 | Femlyv, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $56.91 | 2019-2023 | |
| Scynexis, INC. | $48.87 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $47.17 | 2020-2023 | Slynd |
| Myovant Sciences INC. | $38.36 | 2021 | |
| Hologic Sales and Service, LLC | $35.61 | 2019-2025 | Myosure Tissue Removal Device |
| Exact Sciences Corporation | $24.74 | 2024 | Cologuard Collection Kit |
| Kesin Pharma Corporation | $21.05 | 2023 | Likmez |
| Nalpropion Pharmaceuticals LLC | $20.19 | 2019 | |
| Evofem Biosciences, INC. | $19.48 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.31 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.51 | 2020 | |
| Merck Sharp & Dohme LLC | $11.69 | 2021 | |
| Vivus LLC | $9.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Udell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.